Anida Pharma is a privately owned pre-revenue biopharmaceutical company developing first-in-class treatments for major neurological and pediatric diseases and conditions which currently lack effective treatments: the prevention of brain injury of the newborn, the slowing of disease progression in am…
Anida Pharma is a privately owned pre-revenue biopharmaceutical company developing first-in-class treatments for major neurological and pediatric diseases and conditions which currently lack effective treatments: the prevention of brain injury of the newborn, the slowing of disease progression in amyotrophic lateral sclerosis (ALS; Lou Gehrig disease), and the prevention of drug-induced hearing loss in children undergoing cancer chemotherapy. With excellent experimental proof-of-concept data protected by strong IP Anida now aims to move its programs into clinical development. Anida is led by a professional team of drug developers and is supported by a world class clinical/scientific advisory board.
Team (1)
Sectors Anida Pharma Inc. serves:
Life Sciences
Join Axial's Private M&A Platform
Anida Pharma Inc. connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
